Evidence map›Paper›PMID 26086027›Full record

ArticleJournal of cancer research and therapeutic oncology2015

Immunomodulatory Response Triggered by the Alkaloids, 3-Amino-7-Benzylbenzimidazo[3,2-

Miguel Otero, Beatriz Zayas, Eric Miranda, Christian Velez, Wigberto J Hernandez, Luis A Rivera, Osvaldo Cox

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and therapeutic oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Miguel OteroDepartment of Microbiology and Medical Zoology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Beatriz ZayasUniversidad Metropolitana, School of Environmental Affairs, San Juan, Puerto Rico.
Eric MirandaDepartment of Microbiology and Medical Zoology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico ; Universidad Central del Caribe, School of Medicine, Department of Microbiology and Immunology, Bayamon, Puerto Rico.
Christian VelezUniversidad Metropolitana, School of Environmental Affairs, San Juan, Puerto Rico.
Wigberto J HernandezUniversidad Metropolitana, School of Environmental Affairs, San Juan, Puerto Rico.
Luis A RiveraDepartment of Chemistry, University of Puerto Rico at Mayaguez, Mayaguez, Puerto Rico.
Osvaldo CoxUniversidad Metropolitana, School of Environmental Affairs, San Juan, Puerto Rico.
University of Puerto Rico, Medical Sciences Campus · PR

Funding

SCIENCE AND TECHNOLOGY COMPETENCY & EDUCATION CORE (STCE)P20GM103475 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI SURANGANIE DHARMAWARDHANE · 2012 to 2026
$52.9M
TRANSLATIONAL PROTEOMICS CENTERG12MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FERNANDEZ-REPOLLET, EMMA · 2012 to 2016
$11.0M
UNIVERSIDAD CENTRAL DEL CARIBE BIOMEDICAL RESEARCH CENTERSG12MD007583 · NIMHD · UNIVERSIDAD CENTRAL DEL CARIBE · PI FERNANDEZ, DIANA MARIA · 2012 to 2016
$8.4M
NIGMS NIH HHS P20 GM103475NIMHD NIH HHS G12 MD007583NIMHD NIH HHS G12 MD007600
6 · The paper itself

Abstract

ABQ-48 (3-amino-7-benzylbenzimidazo[3,2-

Indexed as

AlkaloidsAnti cancerBQSHypoxiaImmune modulation

Identifiers

PMID26086027
PMCPMC4467908
OpenAlexW1968521897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.